A 70 years old hypeensive patient with stage 5 chronic kidney disease was diagnosed recently with Type 2 diabetes mellitus. He doesn't want to take injectable insulin. Which of the following oral hypoglycemic agents will be preferred in this patient, which won't require any renal dose modification?
High-Yield Explanation
Answer- A. Linagliptinlinagliptin has the ability to be safely dosed in chronic kidney disease patients. Chronic kidney disease is a major complication in type 2 diabetesLinagliptin .No dose required linagliptin for patients with renal impairment